Erectile dysfunction in chronic kidney disease: From pathophysiology to management

Area of Science:

• Nephrology
• Urology
• Cardiology

Background:

• Chronic kidney disease (CKD) affects millions globally, with increasing incidence and impact on patient quality of life.
• Sexual dysfunction, particularly erectile dysfunction, is highly prevalent in men with CKD, affecting up to 70% in end-stage renal disease.
• Shared pathophysiological factors like vascular/hormonal abnormalities and comorbidities (cardiovascular disease, hypertension, diabetes) link CKD and sexual dysfunction.

Purpose of the Study:

• To highlight the significant prevalence of sexual dysfunction in CKD patients.
• To emphasize the under-recognition and under-treatment of sexual dysfunction in this population.
• To advocate for a comprehensive management strategy to improve patient quality of life and cardiovascular outcomes.

Main Methods:

• This review synthesizes existing literature on the relationship between CKD and sexual dysfunction.
• It examines shared etiological factors and the impact of comorbidities.
• Prevalence data for erectile dysfunction in end-stage renal disease is discussed.

Main Results:

• Sexual dysfunction is a common and often overlooked complication in CKD patients.
• Erectile dysfunction prevalence is notably high, reaching 70% in end-stage renal disease.
• Under-treatment of sexual dysfunction contributes to reduced quality of life.

Conclusions:

• Sexual dysfunction is a significant issue in CKD that requires greater clinical attention.
• A multifactorial approach to management is essential for improving patient well-being.
• Addressing sexual dysfunction may positively impact cardiovascular outcomes in CKD patients.